No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
EPAC Enerpac Tool
- 35.240
- +0.220+0.63%
Close Apr 22 16:00 ET
1.91BMarket Cap28.42P/E (TTM)
35.530High35.070Low251.92KVolume35.140Open35.020Pre Close8.88MTurnover0.47%Turnover Ratio42.98P/E (Static)54.25MShares35.91652wk High5.67P/B1.90BFloat Cap22.90652wk Low0.04Dividend TTM53.78MShs Float70.756Historical High0.11%Div YieldTTM1.31%Amplitude2.165Historical Low35.246Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Zacks.com Featured Highlights Include Interface, International Seaways and Enerpac Tool
Estimating The Intrinsic Value Of Enerpac Tool Group Corp. (NYSE:EPAC)
3 Must-Buy Efficient Stocks for Solid Gains Amid Volatility
Enerpac Tool Group Corp. (NYSE:EPAC) Q2 2024 Earnings Call Transcript
Enerpac Tool Group Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Earnings Call Summary | Enerpac Tool(EPAC.US) Q2 2024 Earnings Conference
The following is a summary of the Enerpac Tool Group Corp. (EPAC) Q2 2024 Earnings Call Transcript:Financial Performance:Enerpac Tool Group reported Q2 organic sales growth in Industrial Tools & Servi
Comments
Enerpac Tool Group's rapid EPS growth and large insider investment make it an attractive investment. Its strong financial performance indicates a potential opportunity. However, investors should note the company's 1 warning sign.
If EPS Growth Is Important To You, Enerpac Tool Group (NYSE:EPAC) Presents An Opportunity 1
Enerpac Tool Group's impressive ROCE trend suggests a turnaround with higher returns on lower capital. However, investors may not fully recognize these promising fundamentals, indicating potential for further stock research.
Enerpac's high P/E ratio echoes its superior future earnings outlook, convincing shareholders to hold onto their stocks. Despite some industry debates, P/E ratio remains a strong business sentiment marker.
Enerpac Tool Group's rapid EPS growth and significant insider ownership mark it as a company to watch. Yet, investors should also consider potential risks.
ColumnsToday's pre-market stock movers: BBIO, LZB, ORA, DOW and more
Gainers:
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
8
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg